<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.3" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Comments on: FDA Approves New SPRYCELÃ (Dasatinib) Product Labeling For Patients With Chronic-Phase CML Part 4</title>
	<link>http://newdiabetesphysicians.newportupdate.net/2008/08/10/fda-approves-new-sprycela%c2%83-dasatinib-product-labeling-for-patients-with-chronic-phase-cml-part-4/</link>
	<description>Welcome to New Port Blogs</description>
	<pubDate>Thu, 08 Jan 2009 22:35:36 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.3.3</generator>
	</channel>
</rss>
